Innovation in biomedicine: Can stem cell research lead the way to affordability?
2006

Stem Cell Research and Affordability

publication

Author Information

Author(s): Merrill Goozner

Primary Institution: Center for Science in the Public Interest

Hypothesis

Can stem cell research lead to affordable treatments for patients?

Conclusion

The study suggests that a combination of a patent pool, open-source model, and shared prize system could make stem cell therapies more affordable.

Supporting Evidence

  • California voters approved a US$3 billion stem cell research program in 2004.
  • The California Institute for Regenerative Medicine aims to ensure affordable treatments.
  • Patent thickets may slow down stem cell research and innovation.
  • A patent pool could facilitate access to necessary research tools.
  • A shared prize model could incentivize collaboration in developing therapies.

Takeaway

This study talks about how California's stem cell research can help make new medicines cheaper for everyone. It suggests working together and sharing ideas to make this happen.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030126

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication